Empirical antibiotic therapy for fever in neutropenic patients.
暂无分享,去创建一个
[1] R. Benjamin,et al. Outpatient treatment of febrile episodes in low‐risk neutropenic patients with cancer , 1993, Cancer.
[2] A. Gikas,et al. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans , 1993, Antimicrobial Agents and Chemotherapy.
[3] G. Bodey,et al. Diagnosis and management of perianal and perirectal infection in the granulocytopenic patient. , 1993, Current clinical topics in infectious diseases.
[4] L. Elting,et al. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] Z. Abbas,et al. Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients , 1992, The Lancet.
[6] B. Kramer,et al. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study , 1992, Antimicrobial Agents and Chemotherapy.
[7] R. Finberg,et al. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] G. Jacoby,et al. More extended-spectrum beta-lactamases , 1991, Antimicrobial Agents and Chemotherapy.
[9] T. Calandra,et al. Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperati , 1991, Antimicrobial Agents and Chemotherapy.
[10] L. Elting,et al. Septicemia Due to Xanthomonas Species and Non‐Aeruginosa Pseudomonas Species: Increasing Incidence of Catheter‐Related Infections , 1990, Medicine.
[11] N. Woodford,et al. Resistance to vancomycin and teicoplanin: an emerging clinical problem , 1990, Clinical Microbiology Reviews.
[12] G. Wormser,et al. Infection due to Leuconostoc species: six cases and review. , 1990, Reviews of infectious diseases.
[13] D. Snydman,et al. Nosocomial sepsis associated with interleukin-2. , 1990, Annals of internal medicine.
[14] E. Anaissie,et al. β‐Lactam regimens for the febrile neutropenic patient , 1990 .
[15] F. Holmes,et al. Oral ciprofloxacin therapy for infections in cancer patients. , 1989, The Journal of antimicrobial chemotherapy.
[16] N. Woodford,et al. High-level vancomycin-resistant enterococci causing hospital infections , 1989, Epidemiology and Infection.
[17] P. Roberson,et al. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. , 1988, The New England journal of medicine.
[18] E. Anaissie,et al. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients. , 1988, The American journal of medicine.
[19] S. Steinberg,et al. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. , 1988, Annals of internal medicine.
[20] M. Tattersall,et al. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. , 1988, European journal of cancer & clinical oncology.
[21] L. Elting,et al. Imipenem/cilastatin therapy of infections in cancer patients , 1987, Cancer.
[22] D. Longo,et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. , 1986, The New England journal of medicine.
[23] L. Elting,et al. Aztreonam therapy in neutropenic patients with cancer. , 1986, The American journal of medicine.
[24] J. Karp,et al. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. , 1986, The American journal of medicine.
[25] G. Bodey,et al. Infection in cancer patients. A continuing association. , 1986, The American journal of medicine.
[26] H. Gaya,et al. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients , 1986, Antimicrobial Agents and Chemotherapy.
[27] L. Elting,et al. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. , 1985, Archives of internal medicine.
[28] J. Mark,et al. Open lung biopsy in patients with acute leukemia. , 1985, The American journal of medicine.
[29] M. Piccart,et al. Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia , 1984, Antimicrobial Agents and Chemotherapy.
[30] G. Bodey. Antibiotics in patients with neutropenia. , 1984, Archives of internal medicine.
[31] M. Keating,et al. Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients , 1984, Antimicrobial Agents and Chemotherapy.
[32] R. Warren,et al. Neutropenic enterocolitis due to Clostridium septicum infection. , 1984, Journal of clinical pathology.
[33] L. Gentry,et al. A Randomized Study of Tobramycin Plus Ticarcillin, Tobramycin Plus Cephalothin and Ticarcillin, or Tobramycin Plus Mezlocillin in the Treatment of Infection in Neutropenic Patients with Malignancies , 1984, The American journal of the medical sciences.
[34] L. Elting,et al. Cefoperazone for the treatment of infections in patients with cancer. , 1983, Reviews of infectious diseases.
[35] L. Elting,et al. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. , 1983, The Journal of antimicrobial chemotherapy.
[36] M. Keating,et al. Combination therapy with ticarcillin and sulfamethoxazole-trimethoprim for infections in patients with cancer. , 1981, Archives of internal medicine.
[37] R. Stuart,et al. Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study. , 1980, The American journal of medicine.
[38] P. Pizzo,et al. Treatment of gram‐positive septicemia in cancer patients , 1980, Cancer.
[39] R. Feld,et al. β-Lactum antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients , 1976, The American journal of the medical sciences.
[40] E. Sickles,et al. Clinical presentation of infection in granulocytopenic patients. , 1975, Archives of internal medicine.
[41] G. Bodey,et al. Antibiotic combinations for infections in neutropenic patients. Evaluation of carbenicillin plus either cephalothin or kanamycin , 1972, Cancer.
[42] G. Bodey. Fungal infections complicating acute leukemia. , 1966, Journal of chronic diseases.